Jacobs Levy Equity Management
NUS icon

Jacobs Levy Equity Management’s Nu Skin NUS Stock Holding History

Jacobs Levy Equity Management’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51,323
Closed -$354K – 1160
2024
Q4 		$354K Sell
51,323
-2,395
-4% -$16.5K ﹤0.01% 857
2024
Q3 		$396K Sell
53,718
-263,870
-83% -$2.47M ﹤0.01% 861
2024
Q2 		$3.35M Buy
317,588
+34,233
+12% +$434K 0.01% 508
2024
Q1 		$3.92M Buy
283,355
+181,528
+178% +$2.83M 0.02% 474
2023
Q4 		$1.98M Buy
+101,827
New +$1.88M 0.01% 605
2022
Q3 		– Sell
-105,881
Closed -$4.58M – 1114
2022
Q2 		$4.58M Sell
105,881
-24,921
-19% -$1.14M 0.04% 432
2022
Q1 		$6.26M Buy
130,802
+20,690
+19% +$1.03M 0.04% 376
2021
Q4 		$5.59M Buy
+110,112
New +$4.89M 0.04% 405
2020
Q1 		– Sell
-53,096
Closed -$2.18M – 1063
2019
Q4 		$2.18M Buy
53,096
+5,406
+11% +$221K 0.02% 526
2019
Q3 		$2.03M Sell
47,690
-65,915
-58% -$2.77M 0.02% 505
2019
Q2 		$5.6M Sell
113,605
-104,449
-48% -$5.31M 0.08% 319
2019
Q1 		$10.4M Buy
218,054
+68,475
+46% +$4.15M 0.15% 176
2018
Q4 		$9.17M Buy
149,579
+58,341
+64% +$3.94M 0.16% 151
2018
Q3 		$7.52M Buy
91,238
+9,675
+12% +$769K 0.11% 226
2018
Q2 		$6.38M Sell
81,563
-27,270
-25% -$2.11M 0.1% 251
2018
Q1 		$8.02M Buy
108,833
+9,120
+9% +$647K 0.13% 208
2017
Q4 		$6.8M Buy
+99,713
New +$6.45M 0.12% 226
2017
Q3 		– Sell
-11,400
Closed -$716K – 1005
2017
Q2 		$716K Sell
11,400
-58,970
-84% -$3.36M 0.02% 623
2017
Q1 		$3.91M Sell
70,370
-58,476
-45% -$3.01M 0.08% 297
2016
Q4 		$6.16M Sell
128,846
-24,540
-16% -$1.37M 0.12% 228
2016
Q3 		$9.94M Buy
+153,386
New +$8.62M 0.18% 165
2014
Q2 		– Sell
-116,406
Closed -$9.64M – 898
2014
Q1 		$9.64M Sell
116,406
-170,140
-59% -$14.9M 0.16% 175
2013
Q4 		$39.6M Buy
286,546
+66,906
+30% +$7.88M 0.6% 34
2013
Q3 		$21M Buy
219,640
+186,690
+567% +$15.8M 0.36% 83
2013
Q2 		$2.01M Buy
+32,950
New +$1.83M 0.04% 416

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management's NUS Position: Q1 2025 in Review

Jacobs Levy Equity Management sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 51,323 shares — an estimated $354K sold.

Jacobs Levy Equity Management first reported a position in NUS in Q2 2013 and held it in 25 quarters. The position peaked at $39.6M in Q4 2013. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.

  • Jacobs Levy Equity Management reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 51,323 Nu Skin shares in Q1 2025, an estimated $354K.
  • Jacobs Levy Equity Management first reported a position in Nu Skin in Q2 2013 and held it in 25 quarters.
  • Jacobs Levy Equity Management's Nu Skin position peaked at $39.6M in Q4 2013.
  • 195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2025, filed 15 May 2025.